{[(3-chlorophenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 1g

2-(5-Methylpyridin-2-yl)acetic acid hydrochloride, 95.0%, 1g

N-(tert-Butoxycarbonyl)-S-benzyl-L-cysteine>98.0%(HPLC)(T)5g

(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid, 98%, 1g

Methyl (6-chloro-1H-benzo[d]imidazol-2-yl)carbamate, 95.0%, 100mg

Bolsas de envío docuCARE® med, formato A5, 500 Unidad(es)

(4-(TRIPHENYLSILYL)PHENYL)BORONIC ACID, 95%, 5g

2,5-Dichloroanisole5g

3-Iodo-5-methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine, 95+%, 250mg

Pentahidrato de sal disódica de β-glicerofosfato, 250 g

4-Methoxy-1-methyl-pyridin-2-one, 95+%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-methylheptanoic acid, 95.0%, 500mg

Perfluorophenyl 4-(5-(trifluoromethyl)pyridin-2-yl)benzoate, 98%, 1g